Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of cyclosporine, an anti-rejection drug,
on the clearance of the hepatitis C virus in liver transplant subjects being treated with
peg-interferon and ribavirin.